Francesca Cendali
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucosephosphate Dehydrogenase | 5 | 2026 | 70 | 1.520 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 3 | 2025 | 34 | 1.280 |
Why?
| | Anemia, Sickle Cell | 7 | 2026 | 324 | 1.080 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 243 | 0.730 |
Why?
| | Exercise Tolerance | 1 | 2025 | 289 | 0.730 |
Why?
| | Erythrocytes | 8 | 2025 | 750 | 0.610 |
Why?
| | beta-Thalassemia | 3 | 2025 | 40 | 0.570 |
Why?
| | Metabolome | 4 | 2025 | 390 | 0.470 |
Why?
| | Hemolysis | 4 | 2025 | 242 | 0.460 |
Why?
| | Proteome | 4 | 2025 | 520 | 0.430 |
Why?
| | Hemopexin | 2 | 2025 | 40 | 0.430 |
Why?
| | Disease Models, Animal | 9 | 2026 | 4580 | 0.370 |
Why?
| | Metabolomics | 7 | 2025 | 738 | 0.330 |
Why?
| | Hypertension, Pulmonary | 4 | 2026 | 1957 | 0.320 |
Why?
| | Proteomics | 6 | 2025 | 1203 | 0.280 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2023 | 893 | 0.250 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2026 | 87 | 0.230 |
Why?
| | Oxidative Stress | 4 | 2025 | 1369 | 0.230 |
Why?
| | Iron | 2 | 2025 | 359 | 0.220 |
Why?
| | Maple Syrup Urine Disease | 1 | 2025 | 5 | 0.220 |
Why?
| | Haptoglobins | 1 | 2025 | 71 | 0.220 |
Why?
| | Cation Transport Proteins | 1 | 2026 | 120 | 0.220 |
Why?
| | Lung | 4 | 2025 | 4122 | 0.220 |
Why?
| | Transcriptome | 2 | 2022 | 1068 | 0.210 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.210 |
Why?
| | Connective Tissue Diseases | 1 | 2025 | 85 | 0.210 |
Why?
| | Blood Coagulation Disorders | 2 | 2023 | 190 | 0.210 |
Why?
| | Heme | 1 | 2025 | 90 | 0.210 |
Why?
| | Animals | 16 | 2026 | 38107 | 0.210 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2024 | 109 | 0.210 |
Why?
| | Bleomycin | 1 | 2025 | 255 | 0.200 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 14 | 0.200 |
Why?
| | Mice | 10 | 2026 | 18297 | 0.200 |
Why?
| | Balloon Occlusion | 1 | 2024 | 39 | 0.200 |
Why?
| | Sickle Cell Trait | 1 | 2023 | 16 | 0.190 |
Why?
| | Viral Nonstructural Proteins | 1 | 2023 | 64 | 0.190 |
Why?
| | Blood Preservation | 3 | 2022 | 346 | 0.190 |
Why?
| | Spleen | 1 | 2025 | 503 | 0.190 |
Why?
| | Multiple Trauma | 1 | 2024 | 118 | 0.180 |
Why?
| | Antifibrinolytic Agents | 1 | 2023 | 68 | 0.180 |
Why?
| | Tranexamic Acid | 1 | 2023 | 63 | 0.180 |
Why?
| | Amino Acid Transport System y+ | 1 | 2022 | 10 | 0.180 |
Why?
| | Sertoli Cells | 1 | 2022 | 26 | 0.180 |
Why?
| | Pulmonary Artery | 2 | 2025 | 1116 | 0.180 |
Why?
| | Fibrinolysis | 1 | 2023 | 162 | 0.180 |
Why?
| | Ribosomes | 1 | 2023 | 196 | 0.180 |
Why?
| | Cardiopulmonary Bypass | 1 | 2024 | 217 | 0.170 |
Why?
| | Rejuvenation | 1 | 2022 | 18 | 0.170 |
Why?
| | Polyamines | 1 | 2022 | 42 | 0.170 |
Why?
| | Athletic Performance | 1 | 2023 | 78 | 0.170 |
Why?
| | Pulmonary Fibrosis | 1 | 2025 | 395 | 0.170 |
Why?
| | Blood | 1 | 2022 | 107 | 0.170 |
Why?
| | Aurora Kinase B | 1 | 2021 | 10 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.160 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 32 | 0.160 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 195 | 0.160 |
Why?
| | DNA Methylation | 1 | 2026 | 725 | 0.160 |
Why?
| | Interferons | 1 | 2022 | 186 | 0.160 |
Why?
| | Androgens | 1 | 2022 | 179 | 0.160 |
Why?
| | Aniline Compounds | 1 | 2021 | 120 | 0.160 |
Why?
| | Pyrazines | 1 | 2021 | 94 | 0.160 |
Why?
| | Protein Biosynthesis | 1 | 2023 | 449 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2021 | 81 | 0.160 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 356 | 0.160 |
Why?
| | Host-Pathogen Interactions | 1 | 2023 | 366 | 0.150 |
Why?
| | Databases, Genetic | 1 | 2021 | 239 | 0.150 |
Why?
| | Physical Exertion | 1 | 2021 | 204 | 0.150 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2134 | 0.150 |
Why?
| | Humans | 26 | 2026 | 146342 | 0.140 |
Why?
| | Hypoxia | 1 | 2026 | 1211 | 0.140 |
Why?
| | Hemorrhage | 1 | 2023 | 825 | 0.130 |
Why?
| | Liver Transplantation | 1 | 2025 | 751 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 931 | 0.130 |
Why?
| | Mitochondria | 1 | 2024 | 997 | 0.130 |
Why?
| | Swine | 3 | 2024 | 821 | 0.120 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 747 | 0.120 |
Why?
| | Oxygen | 1 | 2022 | 997 | 0.120 |
Why?
| | Liver | 1 | 2025 | 1864 | 0.120 |
Why?
| | Exercise | 3 | 2025 | 2213 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2026 | 2537 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2021 | 1432 | 0.110 |
Why?
| | Male | 14 | 2026 | 73396 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1818 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 702 | 0.100 |
Why?
| | Pyrroles | 2 | 2026 | 222 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2021 | 1339 | 0.100 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 20 | 0.100 |
Why?
| | Anti-HIV Agents | 1 | 2020 | 914 | 0.090 |
Why?
| | Rats | 3 | 2026 | 5586 | 0.090 |
Why?
| | Prognosis | 1 | 2021 | 4351 | 0.090 |
Why?
| | Kynurenine | 2 | 2023 | 114 | 0.090 |
Why?
| | Blood Coagulation | 2 | 2024 | 267 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 120 | 0.080 |
Why?
| | Indoles | 2 | 2026 | 511 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2023 | 2418 | 0.080 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 6034 | 0.070 |
Why?
| | Homeostasis | 2 | 2023 | 646 | 0.070 |
Why?
| | Amino Acids | 2 | 2023 | 515 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3545 | 0.060 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2025 | 39 | 0.050 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 96 | 0.050 |
Why?
| | HIV Infections | 1 | 2020 | 3215 | 0.050 |
Why?
| | Heme Oxygenase-1 | 1 | 2025 | 76 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2023 | 2791 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 35 | 0.050 |
Why?
| | Diethylhexyl Phthalate | 1 | 2024 | 13 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 146 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 104 | 0.050 |
Why?
| | Phthalic Acids | 1 | 2024 | 43 | 0.050 |
Why?
| | Plastics | 1 | 2024 | 50 | 0.050 |
Why?
| | Ovalbumin | 1 | 2024 | 187 | 0.050 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2024 | 151 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2022 | 3647 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 36 | 0.050 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 106 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2026 | 612 | 0.050 |
Why?
| | Succinates | 1 | 2023 | 25 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 23 | 0.050 |
Why?
| | Female | 7 | 2025 | 79499 | 0.050 |
Why?
| | Injections, Intramuscular | 1 | 2023 | 140 | 0.050 |
Why?
| | Lactates | 1 | 2023 | 82 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2023 | 117 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 342 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 300 | 0.050 |
Why?
| | Conserved Sequence | 1 | 2023 | 242 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 163 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 366 | 0.050 |
Why?
| | Leydig Cells | 1 | 2022 | 14 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2024 | 208 | 0.050 |
Why?
| | Cystine | 1 | 2022 | 17 | 0.040 |
Why?
| | Bicycling | 1 | 2023 | 117 | 0.040 |
Why?
| | Glutamates | 1 | 2022 | 66 | 0.040 |
Why?
| | Thrombelastography | 1 | 2023 | 182 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 263 | 0.040 |
Why?
| | Spermatogenesis | 1 | 2022 | 87 | 0.040 |
Why?
| | Sulfur | 1 | 2022 | 60 | 0.040 |
Why?
| | Testis | 1 | 2022 | 158 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2025 | 565 | 0.040 |
Why?
| | Luteinizing Hormone | 1 | 2022 | 206 | 0.040 |
Why?
| | Erythrocyte Count | 1 | 2021 | 20 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 46 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2025 | 571 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 51 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 91 | 0.040 |
Why?
| | Erythrocyte Deformability | 1 | 2021 | 23 | 0.040 |
Why?
| | Aorta | 1 | 2024 | 440 | 0.040 |
Why?
| | Purines | 1 | 2022 | 188 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 97 | 0.040 |
Why?
| | Cysteine | 1 | 2022 | 210 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 538 | 0.040 |
Why?
| | Fluorenes | 1 | 2020 | 46 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 585 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 113 | 0.040 |
Why?
| | Sofosbuvir | 1 | 2020 | 63 | 0.040 |
Why?
| | Glutathione | 1 | 2022 | 369 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 2020 | 103 | 0.040 |
Why?
| | Exome | 1 | 2021 | 233 | 0.040 |
Why?
| | Tryptophan | 1 | 2021 | 184 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2023 | 403 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 882 | 0.040 |
Why?
| | Alanine | 1 | 2020 | 171 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2022 | 226 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 295 | 0.040 |
Why?
| | Blood Donors | 1 | 2021 | 145 | 0.040 |
Why?
| | Benzimidazoles | 1 | 2020 | 191 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1888 | 0.040 |
Why?
| | Adult | 4 | 2025 | 41087 | 0.030 |
Why?
| | Tenofovir | 1 | 2020 | 300 | 0.030 |
Why?
| | Kinetics | 1 | 2022 | 1553 | 0.030 |
Why?
| | Acute Disease | 1 | 2021 | 1038 | 0.030 |
Why?
| | Lipids | 1 | 2023 | 714 | 0.030 |
Why?
| | Fatty Acids | 1 | 2021 | 460 | 0.030 |
Why?
| | Adenine | 1 | 2020 | 339 | 0.030 |
Why?
| | Testosterone | 1 | 2022 | 419 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2021 | 721 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 611 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 540 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2861 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 36619 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2867 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 594 | 0.030 |
Why?
| | Macrophages | 1 | 2023 | 1532 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2022 | 3125 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 983 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1792 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2921 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2458 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6460 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 6077 | 0.020 |
Why?
| | Infant | 1 | 2024 | 10114 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 8123 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 11913 | 0.020 |
Why?
| | Aged | 1 | 2025 | 26432 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 22557 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14330 | 0.010 |
Why?
| | Child | 1 | 2024 | 22693 | 0.010 |
Why?
|
|
Cendali's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|